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Oocytes acquire developmental competence with progressive folliculogenesis. Cumulus oocyte com-
plexes (COCs) from small antral follicles have inherent low competence and are poorly responsive to
amphiregulin (AREG) which normally mediates oocyte maturation and ovulation. Using low competence
porcine COCs, in an in vitro AREG-induced oocyte maturation system, the combined exposure to N(6),2ʹ-
O-dibutyryladenosine 3′:5′ cyclic monophosphate (cAMP) and bone morphogenetic protein 15 (B15) and
growth differentiation factor 9 (G9) was necessary to enhance the rate of oocyte meiotic maturation and
blastocyst formation. Furthermore, the combination of cAMPþB15þG9 enabled AREG-stimulated
cumulus expansion and increased expression of the matrix-related genes HAS2, TNFIPA6 and PTGS2.
Additionally, the combination enhanced p-ERK1/2 which is downstream of the EGF receptor. The
enhanced nuclear maturation and blastocyst formation rates with the combinational treatment were
ablated by an EGF receptor phosphorylation inhibitor. These results indicate that cAMP and oocyte-
secreted factors cooperate to promote EGF receptor functionality in developing COCs, representing a key
component of the acquisition of oocyte developmental competence.
Crown Copyright & 2015 Published by Elsevier Inc. All rights reserved.Introduction
Complex cellular processes occur during the oocyte growth and
development phase within the ovarian follicular environment, that
ultimately determine the oocyte's developmental competence,
deﬁned as the capacity of the oocyte to undergo fertilization, early
preimplantation embryo development and to support develop-
ment to term (Gilchrist and Thompson, 2007). Signiﬁcantly, oocyte
developmental competence underpins fetal and neonatal health
and development, postnatal health and prevention of program-
mable diseases (Gilchrist and Thompson, 2007; Mtango et al.,
2008). Oocyte development is coordinated by a complex interplay
between the oocyte's own developmental program and directives
and nutrients from the somatic cell compartment, especially fromevier Inc. All rights reserved.
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rist).the granulosa and cumulus cells. These somatic cells respond to
endocrine stimulation by the gonadotropins (follicle stimulating
hormone (FSH) and luteinizing hormone (LH)), which in turn
interact with a complex array of local growth factors and steroids.
During the late phase of antral folliculogenesis, prior to the LH
surge, FSH binds to the FSH receptor and stimulates the expression
of LH receptors (LHR) on mural granulosa cells (Erickson et al.,
1979) and epidermal growth factor receptors (EGFR) on cumulus
cells (El-Hayek et al., 2014). Oocyte meiotic maturation occurs
during the period between the LH surge and ovulation. LH induces
a rapid and transient expression of the EGF-like peptides;
amphiregulin (AREG), epiregulin (EREG) and betacellulin (BTC),
initially in the mural granulosa cell compartment, and then these
EGF-like peptides bind and activate the EGFR on mural and
cumulus cells, thereby auto-amplifying their own expression
(Hsieh et al., 2007; Park et al., 2004; Shimada et al., 2006). These
events are likely to be restricted to pre-ovulatory cumulus–oocyte
complexes (COCs) as developing COCs in smaller antral follicles are
poorly responsive to EGF ligands (see next section). EGF-like
S. Sugimura et al. / Developmental Biology 403 (2015) 139–149140peptide expression by both mural granulosa and cumulus cells is a
cyclic adenosine 3′,5′-monophosphate (cAMP)–protein kinase A
(PKA) dependent event. During meiotic maturation of COCs, EGF-
like peptides activate downstream effectors of EGFR signaling, in
particular extracellular signal-regulated kinases 1 and 2 (ERK1/2)
and PI(3)K-AKT (Chen et al., 2013) followed by stimulation of gene
expression that enable expansion of cumulus cells (Prochazka
et al., 2012; Shimada et al., 2006; Yamashita et al., 2007) and in
turn leads to closure of cumulus–oocyte gap junctions, which is
required for LH-induced meiotic resumption (Norris et al., 2010).
Cumulus expansion is characterized by production of a complex
proteoglycan-rich extra-cellular matrix that is essential for ovu-
lation and oocyte capture by the infundibrium.
Oocytes gradually and sequentially acquire increasing devel-
opmental competence with advancing folliculogenesis (Eppig
et al., 1992). Hence, oocytes from small antral follicles inherently
have low developmental competence, as evidenced by a poor
capacity to support embryogenesis up to the blastocyst stage, as
opposed to oocytes from large antral follicles which have high
developmental competence (Bagg et al., 2007; Eppig et al., 1992,
1994; Lonergan et al., 1994; Marchal et al., 2002). This is a well-
established concept and provides an invaluable experimental
model to study oocyte developmental competence, as used in the
current study. Underpinning this model is the concept that small
antral follicles will grow into large antral follicles containing
developmentally viable oocytes, given appropriate in vivo condi-
tions (e.g. supply of FSH is typically rate-limiting to growth).
Hence, oocytes in small antral follicles are not intrinsically defec-
tive per se, as simple exposure to exogenous gonadotropins in vivo
(as per controlled ovarian hyperstimulation for IVF) or in vitro,
causes follicles to grow and their oocytes to gain the capacity to
support embryo/fetal development.
Similarly, but less well understood, capacity for expansion of
cumulus cells is also developmentally regulated by folliculogen-
esis; while EGF stimulates expansion of COCs originating from
large antral and preovulatory follicles, COCs from small antral
follicles (o4 mm, porcine) do not expand following EGF treatment
(Prochazka et al., 2003; Ritter et al., 2015). Prochazka et al (2003)
suggested that the failure of less competent COCs to respond to
EGF was caused by the absence or immaturity of the EGFR.
Recently we found that COCs from small antral follicles express
equivalent levels of EGFR mRNA as those from medium follicles,
but notably less EGFR protein, such that EGF fails to activate EGFR
and ERK1/2 in these COCs (Ritter et al., 2015). We recently hypo-
thesized that development of functional EGFR signaling in cumu-
lus cells is likely to constitute a key developmental milestone for
the oocyte (Ritter et al., 2015).
Oocyte-secreted factors (OSFs) such as bone morphogenetic
protein 15 (B15) (Laitinen et al., 1998) and growth differentiation
factor 9 (G9) (Dong et al., 1996), which are members of the
transforming growth factor beta (TGF-β) superfamily, are required
for correct differentiation of cumulus cells which is crucial for
normal oocyte development and maturation (Eppig, 2001;
Gilchrist et al., 2006). OSFs regulate cumulus cell proliferation (Li
et al., 2000), gene expression (Paradis et al., 2010; Regassa et al.,
2011), luteinization (Eppig et al., 1997), metabolism (Sugiura et al.,
2007), apoptosis (Hussein et al., 2005) and expansion of the extra-
cellular matrix (Buccione et al., 1990). In the mouse, G9 and B15
regulate EGFR expression in cumulus cells (Su et al., 2010). Fur-
thermore, in granulosa and cumulus cells, G9 requires the activa-
tion of EGFR–ERK1/2 signaling (Sasseville et al., 2010), suggesting
that oocyte paracrine signals work cooperatively with EGFR sig-
naling to regulate the function of follicular cells in the somatic
compartment of the follicle. In support of this, we have recently
shown that native OSFs (likely some combination of B15 and G9
forms) induces EGF responsiveness in COCs from small antralfollicles and improves their developmental competence (Ritter
et al., 2015). Native OSFs from less developed oocytes were less
effective at inducing EGF responsiveness (Ritter et al., 2015), sug-
gesting that G9 and B15 bio-availability is rate-limiting during the
antral phase of development, consistent with the now ample
evidence supporting the original demonstration that exogenous
G9 and B15 improve oocyte developmental competence (Hussein
et al., 2006).
Cyclic AMP is the second messenger of the gonadotropins and
cAMP/PKA signaling is crucial for production of EGF-like peptides
and has the potential to transactivate the EGFR in mouse follicles
(Conti et al., 2006). PKA phosphorylates many substrates within
the cell including transcription factors SP1/SP3 and CREB that
control transcription of speciﬁc genes in cumulus and granulosa
cells under cAMP control (Gonzalez-Robayna et al., 2000). Thus,
the cAMP–PKA axis may have a crucial role in EGFR signaling,
however, EGF-like peptides do not activate cAMP–PKA in pig COCs
(Prochazka et al., 2011). In addition, cyclic nucleotides are the
central regulators of oocyte meiotic maturation and cAMP has
major effects on oocyte developmental competence (Albuz et al.,
2010; Funahashi et al., 1997; Luciano et al., 1999).
In the present study, our aim was to investigate the participa-
tion of cAMP and OSFs on maturation and/or enhancement of
EGFR signaling in cumulus cells with the hypothesis that this is
important for the acquisition of oocyte developmental compe-
tence. Firstly, we examined interactive effects of AREG and N(6),2'-
O-dibutyryladenosine 3':5' cyclic monophosphate (dbcAMP), as an
established cAMP moderator, on the in vitro development of low
versus medium competence oocytes, derived from small (2–4 mm)
and medium (44–6 mm) antral follicles, respectively. Our results
indicate that AREG in the presence of dbcAMP enhanced oocyte
competence from medium antral follicles but not those from small
antral follicles. Given OSFs induce EGF functionality in cumulus
cells from small antral follicles (Ritter et al., 2015), we examined
the effect of B15 and G9 on cAMP/AREG-induced oocyte meiotic
maturation, developmental competence, cumulus expansion;
cumulus cell expression of transcripts encoding hyaluronic acid
synthase 2 (HAS2), tumor necrosis factor alpha-induced protein 6
(TNFAIP6) and prostaglandin-endoperoxide synthase 2 (PTGS2);
and activation of ERK1/2.Materials and methods
Unless speciﬁed, all chemicals were purchased from Sigma-
Aldrich (St. Louis, MO, USA).
Oocyte collection and in vitro maturation
Gilt (peri-pubertal female pigs) ovaries from a slaughterhouse
(Fig. 1A) were transferred to the laboratory, and then washed and
stored in physiological saline at 38.5 °C. Follicle size was measured
with a Vernier caliper and COCs were aspirated from small (2–
4 mm) or medium (44–6 mm) sized antral follicles, representing
oocytes with low (Fig. 1B) versus moderate (Fig. 1C) develop-
mental competence, respectively (Bagg et al., 2007; Marchal et al.,
2002), using a 10 ml syringe equipped with a 20 gauge needle and
collected in modiﬁed phosphate-buffered saline (PBS) supple-
mented with 5.5 mM glucose, 0.33 mM pyruvate, 100 IU/ml peni-
cillin and 3 mg/ml BSA (Quinn et al., 1982) (Fig. 1B). Compact COCs
with greater than 3 layers of cumulus cells and a homogeneous
ooplasm were cultured in porcine oocyte medium containing
3 mg/ml polyvinyl alcohol (POMþPVA) (Yoshioka et al., 2008), and
depending on the treatment: supplemented with or without
standard porcine oocyte in vitro maturation (IVM) doses of
gonadotropins (Gns) consisting of 10 IU/ml equine chorionic
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human chorionic gonadotropin (Organon, Sydney, Australia) or; 0–
500 ng/ml recombinant human amphiregulin (AREG; R&D Sys-
tems, Minneapolis, MN, USA), in the presence or absence of
1 mmol/L dibutyryl cAMP (cAMP) (Funahashi et al., 1997); 100 ng/
ml recombinant human GDF9 (G9); 100 ng/ml recombinant
human BMP15 (B15); or B15þG9, for 22 h at 38.5 °C in a highly
humidiﬁed atmosphere of 5% CO2 in air. After 22 h COCs were
washed and then transferred into the same medium but without
gonadotropins, AREG, B15, G9 or cAMP for an additional 22 h. G9
and B15 were produced in our laboratory as concentrated pre-
parations of pro/mature-region complexes, produced in 293 T
cells, as previously described (Pulkki et al., 2011, 2012), and as
described as supplements to oocyte IVM medium at the same
doses as used here (Li et al., 2015; Sudiman et al., 2014b; Sugimura
et al., 2014). Ten COCs were incubated in 100 ml of IVM medium,
covered with parafﬁn oil in 35-mm Petri dishes. Approximately 20
COCs were used per treatment per replicate.
Assessment of meiotic status
Following 44 h of IVM, COCs were mechanically denuded by
pipetting and then ﬁxed using 4% paraformaldehyde for 1 h at
4 °C. Fixed oocytes were incubated in a permeating solution (0.5%
triton X-100 and 0.5% sodium citrate) for 15–30 min, followed by
incubation in 3 μM 4′,6-diamidino-2-phenylindole solution in the
dark for 15 min. Oocytes were washed in PBS containing 1 mg/ml
BSA and then mounted on a slide with glycerol. Chromosome
conﬁgurations were assessed using a Nikon Eclipse TE2000-E
microscope (330–380 nm excitation wavelength; Nikon, Melville,
NY, USA).
In vitro embryo production
Following IVM, COCs were denuded of cumulus cells, washed
three times with TUmedium (Miyoshi et al., 1999), and transferred
to a 100 mL drop of TU-medium for IVF (Miyoshi et al., 1999). 1 mL
of fresh semen was washed three times by centrifugation (1000gFig. 1. Gilt ovaries (A) and low developmental competence COCs from small antral
2–4 mm follicles (B) compared to moderate competence COCs from medium-sized
44–6 mm antral follicles (C). Arrows and circles indicate small and medium antral
follicles, respectively.for 5 min) in Dulbecco's PBS supplemented with 1 mg/mL BSA.
Spermatozoa were resuspended in 1 mL of IVF medium and added
to the IVF drop containing oocytes to give a ﬁnal concentration of
5105 sperm/mL. After 1 h of culture, sperm were removed from
putative zygotes by gentle pipetting using a glass pipette. Post-
insemination, oocytes were washed three times and cultured in
modiﬁed porcine zygote medium (PZM)-5 (Suzuki et al., 2004)
supplemented with 3 mg/ml BSA instead of PVA at 38.5 °C in 5%
CO2 in air.
COCs expansion assay
Cumulus expansion was assessed at 22 h of IVM according to
the scoring system of Vanderhyden et al. (1990) and the cumulus
expansion index was calculated (Fagbohun and Downs, 1990).
RNA extraction and real-time RT-PCR analysis
Cumulus cell HAS2, TNFIPA6 and PTGS2 gene expression was
analyzed by real-time PCR as previously described (Gilchrist and
Ritter, 2011). Peptidylprolyl isomerase A (PPIA) was used as the
endogenous control, as this was found to be stably expressed
regardless of the experimental treatments. COCs cultured for 44 h
were mechanically stripped of their cumulus cells by vigorous
pipetting using a 200 ml pipette. Cumulus cells from 30 COCs were
lysed in 300 ml of RTL buffer containing 10 ml/ml of 2-mercap-
toethanol and stored at 80 °C until RNA extraction. Total RNA
was extracted from each sample using the RNeasy Micro Kit
(Qiagen, Valencia, USA) according to the manufacturer's instruc-
tions and quantiﬁed using a NanoDrop spectrophotometer
(Thermo Fisher Scientiﬁc, Scoresby, VIC, Australia). Residual
genomic DNA was removed by digestion with recombinant RNase-
free DNase I (Qiagen). RNA (200 ng) was reverse transcribed with
random primers (Invitrogen Australia, Mount Waverley, Australia)
using Super-Script III (Invitrogen). Quantitative real-time PCR
analysis was performed on a Corbett Rotor-Gene 6000 (Qiagen) in
a 20-ml reaction volume containing 3 ml cDNA, 10 pmol each of
forward and reverse primers (Table 1), 2 ml nuclease-free water
and 10 ml SYBR Green PCR Master Mix (Applied Biosystems, Foster
City, CA, USA). All PCR reactions were carried out in duplicate.
Universal thermal cycling parameters (initial step of 2 min at 50 °C
and 10 min at 95 °C, followed by 40 cycles of 15 s at 95 °C and 60 s
at 60 °C) were used to quantify the expression of all genes. At the
end of the real-time PCR analysis, melting curve analysis was
carried out on the real-time cycler to check the speciﬁcity of the
reaction. A standard curve was generated for the gene of interest
and for the endogenous control gene (PPIA) in every PCR run by
using a serial 5-fold dilution of ampliﬁed cDNA derived from
cumulus cells. Final quantitative analysis of each gene was per-
formed using the standard curve method. Results were normalized
to the housekeeping gene PPIA and expressed relative to a cali-
brator (control-AREG) which was set at 1.
Western blot analysis
Groups of ﬁfty COCs were exposed to in vitro treatments for
1 h and then lysed in RIPA buffer (10 mM Tris, 150 mM NaCl,
1 mM EDTA, 1% Triton X-100) containing phosphatase and pro-
tease inhibitor cocktails (Roche, Penzberg, Germany), and then
snap frozen in liquid nitrogen and stored at 80 °C. Samples
were mixed with loading buffer containing 100 mM dithio-
threitol, heated at 100 °C for 5 min, and loaded onto a 7.5%
(separating) and 4% (stacking) SDS-polyacrylamide gel for elec-
trophoresis. Proteins were transferred to a Hybond-ECL mem-
brane (GE Healthcare, Waukesha, USA), and the membrane cut
horizontally below the 75 kDa marker. The upper section of the
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brane was blocked with 2% blocking reagent (supplied in an ECL
Advance kit; GE Healthcare) diluted in Tris-buffered saline con-
taining 0.1% (v/v) Tween 20. The membrane was incubated with
two antibodies simultaneously, anti-phospho-ERK1/2 (p-ERK1/2;
Sigma) diluted 1:1200 and anti-total-ERK1/2 (t-ERK1/2, Sigma)
diluted 1: 10,000 at 4 °C for 22–26 h, followed by incubation with
goat anti-mouse IgG IRDye™ 680 (Licor Bioscience, Lincoln, USA)
diluted 1: 50,000 and goat anti-rabbit IgG IRDye™ 800 (Licor
Bioscience) diluted 1: 200,000 for 1 h at room temperature.
Membranes were then washed with Tris-buffered saline con-
taining 0.1% (v/v) Tween 20 (TBS-T20) then scanned and quan-
tiﬁed using an Odyssey infrared imaging system (Licor
Bioscience). Band intensities for pERK1/2 were normalized to
t-ERK1/2 and standardized relative to no treatment controls.
Inhibition of EGFR signaling
COCs were cultured for 22 h in POM supplemented with or
without 100 ng/ml AREG and/or 1 mM dbcAMP, 100 ng/ml B15 and
100 ng/ml G9 (cAMPþB15þG9) in the presence or absence of
10 μM AG1478 (an EGFR tyrosine kinase inhibitor), and subse-
quently for 24 h in the same medium, but without any treatments.
Statistical analysis
Data were analyzed using analysis of variance (ANOVA) fol-
lowed by Tukey–Kramer or Dunnett tests. All percentage data
were arcsine transformed prior to ANOVA. For all data, Po0.05
was considered signiﬁcant. All analyses were conducted using
StatView (SAS Institute Inc. NC, USA).0
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Fig. 2. Oocyte meiotic maturation of Gns- or AREG-treated COCs from different
follicle sizes. Metaphase II (MII) rate in COCs cultured with Gns or AREG (0, 5, 10,
50, 100 and 500 ng/ml) was examined in small (A) and medium (B) antral follicle-
derived COCs at 44 h of oocyte maturation. Values represented as mean7SEM of
seven replicate experiments. Asterisk indicates signiﬁcant difference compared
with 0 ng/ml of AREG (Po0.05; ANOVA followed by Dunnett test).Results
COCs from small antral follicles respond poorly to AREG
As expected, in small antral follicle-derived COCs (2–4 mm),
AREG did not stimulate oocyte meiotic maturation at any dose
examined (5–500 ng/ml) (Fig. 2A). In medium follicle-derived
COCs (44–6 mm; Fig. 2B), in general, AREG did not notably induce
oocyte meiotic maturation, although maturation was stimulated at
100 ng/ml AREG (Po0.05), to levels equivalent to the MII rate in
gonadotropin-stimulated COCs (P40.05).
In medium follicle-derived COCs, blastocyst formation rates of
oocytes treated with 100 ng/ml AREG was signiﬁcantly higher
than gonadotropin treated COCs in the presence of exogenous
cAMP, but not in the absence of cAMP (Fig. 3B). However, in small
antral follicle-derived COCs this combined beneﬁt of AREG and
cAMP was not evident (Fig. 3A). Consistent with this established
experimental model of oocyte competence (Bagg et al., 2007;
Marchal et al., 2002), small antral follicle-derived COCs exhibitedTable 1
Sequences of primers for real-time PCR.
Gene name GenBank accession number Prime
HAS2 AB050389.1 F: 5'-
R: 5'-
TNFAIP6 NM_001159607.1 F: 5'-
R: 5'-
PTGS2 NM_214321.1 F: 5'-
R: 5'-
PPIA AY266299.1 F: 5'-
R: 5'-low blastocyst rates (10–20%) regardless of treatment, compared
to COCs from medium follicle-derived COCs (blastocyst range; 40–
60%). These results indicate that COCs from small antral follicles
respond poorly to AREG stimulation in terms of oocyte meiotic
maturation and developmental competence.
Together cAMP, B15 and G9 enhance AREG-induced oocyte matura-
tion and developmental competence of small antral follicle-derived
oocytes
Recently we showed that oocyte-secreted factors enable AREG
signaling in COCs from small antral follicles (Ritter et al., 2015).r sequences forward (F) and reverse (R) Amplicon size (bp)
AGT TTA TGG GCA GCC AAT GTA GTT-3' 101
GCA CTT GGA CCG AGC TGT GT-3'
AGA AGC GAA AGA TGG GAT GCT-3' 106
CAT TTG GGA AGC CTG GAG ATT-3'
AGC AAT TCC AAT ACC AAA ACC GTA T-3' 102
TGT ACT CGT GGC CAT CAA TCT G-3'
CAT TTG CAC TGC CAA GAC TGA-3' 103
GGA CCC AAA GCG CTC CAT-3'
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Fig. 3. Effect of Gns or AREG in the presence or absence of cAMP on developmental competence of oocytes from different follicle sizes. COCs derived from small (A, low
competence) and medium (B, moderate competence) sized antral follicles were cultured with Gns or AREG supplemented medium, with or without cAMP. Effect of
treatments on developmental competence were examined by measuring the following on time embryo developmental milestones: cleaved embryos at day 2 and blastocyst
development on day 8. Blastocyt formation rate was expressed as a percentage of cleaved embryos. All values are represented as mean7SEM of seven replicate experiments.
Bars with different letters indicate signiﬁcant differences at Po0.05.
S. Sugimura et al. / Developmental Biology 403 (2015) 139–149 143Given this knowledge and that AREG interacts with cAMP in COCs
from medium follicle-derived COCs (Fig. 3, current study), we next
explored interactions between these treatments in small antral
follicle-derived COCs. B15, G9, B15þG9, cAMP and cAMPþG9 did
not increase oocyte meiotic maturation of small antral follicle-
derived COCs in AREG-supplemented IVM (Fig. 4A). Oocyte meiotic
maturation was signiﬁcantly increased by combinations of cAMP
and B15, such as, cAMPþB15 and cAMPþB15þG9. Those rates
were similar to MII rates of COCs treated with Gns throughout IVM
(Fig. 4A).
In AREG-supplemented IVM, cleavage rates of small antral
follicle-derived oocytes were unaffected by any additional IVM
treatment (Fig. 4B). Likewise, B15, G9, B15þG9, cAMP, cAMPþB15
and cAMPþG9 did not increase the rates of blastocyst formation in
AREG-supplemented IVM (Fig. 4C). By contrast, the combination of
cAMP, B15 and G9 notably increased the blastocyst formation rate
by 3.3-fold (from 14% to 47%; Po0.05; Fig. 4C).cAMP, BMP15 and GDF9 synergistically promote EGFR signaling
which is activated by AREG
Cumulus cell production of extracellular matrix molecules is a
hallmark of cumulus cell differentiation, is required for the ovu-
latory cascade, and the expression of key associated genes are
mediated by EGFR signaling (Conti et al., 2012). We measured
cumulus expansion and expression of relevant genes such as HAS2,
TNFIP6 and PTGS2 within cumulus cells of small antral follicle-
derived COCs treated with or without AREG in the presence or
absence of B15þG9 and/or cAMP (Fig. 5). Overall, cAMP and
B15þG9 did not promote morphological cumulus expansion
(Fig. 5A and B) or expression of any matrix gene (Fig. 5C) in the
absence of AREG, nor were these affected by the combination of
cAMP and B15þG9. In contrast, in the presence of AREG, addition
of cAMP and B15þG9 signiﬁcantly improved cumulus expansion
(Fig. 5A and B) and expression of all the matrix-related genes.
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Fig. 4. Oocyte meiotic maturation and developmental competence of low compe-
tence oocytes treated with AREG in the presence or absence of B15, G9 and cAMP.
Metaphase II (MII) rates of COCs cultured with Gns or AREG was examined in small
antral follicle-derived COCs at 44 h of maturation (A). Developmental competence
of COCs treated with AREG in the presence or absence of B15, G9 and cAMP was
examined by scoring 2 important embryo developmental milestones: cleavage on
day 2 (B) and blastocysts development on day 8 (C). Blastocyst formation rate was
expressed as a percentage of cleaved embryos. All values are represented as
mean7SEM of seven replicate experiments. Bars with different letters indicate
signiﬁcant difference at Po0.05.
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treated with B15þG9 alone or cAMP alone (Fig. 5C), suggesting
that the combined actions of cAMP, B15 and G9 are required for
AREG-induction of cumulus expansion and expression of related
genes in COCs from small antral follicles.
ERK1/2 is the best documented kinase activated by EGFR in
cumulus cells. EGF-like peptide activation of cumulus cell EGFR–
ERK1/2 signaling is central to cumulus expansion and oocytematuration (Park et al., 2004). As expected, cumulus cell ERK1/2
was activated by Gns and AREG (Fig. 6). The level of AREG-induced
ERK1/2 activation was signiﬁcantly enhanced by the combination
of cAMP and B15þG9, but not by either cAMP alone or B15þG9.
Collectively these results suggest that cAMP, B15 and G9 syner-
gistically promote cumulus cell EGFR–ERK1/2 signaling when
activated by AREG.
EGFR signaling promoted by cAMP, BMP15 and GDF9 participates in
the developmental competence of small antral follicle-derived oocytes
In AREG-induced oocyte maturation, meiotic and develop-
mental competence were enhanced by the cooperative effects of
cAMP, B15 and G9 (Fig. 4). For investigating whether such
improvements in oocyte quality occur independent of EGFR or are
a function of EGFR signaling, we examined the effect of AG1478,
which is a well-established inhibitor of EGFR tyrosine kinase, on
oocyte meiotic maturation and developmental competence
(Fig. 7). AG1478 signiﬁcantly decreased the additive beneﬁts of
cAMPþB15þG9 and AREG on oocyte meiotic maturation, low-
ering MII rates to control levels (Fig. 7A). Similarly, AG1478
antagonized the combined beneﬁts of cAMPþB15þG9 and AREG
on blastocyst formation (Po0.05; Fig. 7C). In the absence of
cAMPþB15þG9 (Fig. 7) or in the absence of AREG (data not
shown), AG1478 had no effect on oocyte meiotic or developmental
competence. These results suggest that improved oocyte devel-
opmental competence by cAMP, B15 and G9 in the presence of
AREG is likely to result from the effects of these treatments on
enhanced EGFR signaling.
In small antral follicle-derived COCs that have inherently low
developmental competence, no effect of gonadotropins or AREG
was observed on oocyte developmental competence, regardless of
the presence of cAMP (Fig. 3). Given the synergistic effect we
observed of B15þG9þcAMP on AREG-induced cumulus cell
function associated with EGFR signaling (Figs. 5–7), we next
compared the effect of this combination to gonadotropins on
oocyte developmental competence (Fig. 8). There was no sig-
niﬁcant difference in cleavage rates among all groups (P40.05;
Fig. 8A). Blastocyst formation rate was signiﬁcantly higher in
AREG-stimulated IVM with cAMPþB15þG9 compared to Gns
with B15þG9 with/without cAMP, or AREG-stimulated IVM with
B15þG9 (Fig. 8B). These results indicate that AREG in the presence
of cAMP and B15þG9 seems to be advantageous over gonado-
tropins as a stimulator of developmental competence of oocytes
from small antral follicles.Discussion
The ﬁnal phase of oocyte maturation and ovulation are medi-
ated by the EGF-like peptides; AREG, EREG and BTC (Park et al.,
2004). Functional EGFR signaling is a developmentally regulated
event in the ovarian follicle and the acquisition of somatic cell
signaling capability is likely to be an important developmental
milestone for the oocyte. Oocytes in growing small antral follicles
have inherent low developmental competence and are poor
responders to EGF or the EGF-like peptides (Prochazka et al., 2003;
Ritter et al., 2015). By contrast, AREG and EREG support oocyte
maturation and developmental competence of more devel-
opmentally advanced oocytes from large antral follicles (Prochazka
et al., 2011; Richani et al., 2013; Sugimura et al., 2014). Here we
demonstrate that cAMP, and the oocyte paracrine factors, B15 and
G9, cooperatively enhance EGFR signaling stimulated by AREG in
developing COCs derived from small antral follicles, thereby
enhancing oocyte developmental competence (Fig. 9).
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et al., 2003, 2000; Ritter et al., 2015), less competent, small antral
follicle-derived COCs responded poorly to AREG, whereas in
medium follicle-derived COCs, AREG stimulated oocyte meiotic
maturation and enhanced oocyte competence in the presence of
cAMP. The immaturity of the EGFR in cumulus cells from less
competent oocytes could be a function of deﬁciencies at a number
of different levels. Some studies have suggested reduced EGFR
mRNA expression in these cumulus cells (Caixeta et al., 2009; El-
Hayek et al., 2014), although recently, using the same experi-
mental model as the current study, we found equivalent EGFR
mRNA levels in cumulus from small versus medium antral follicles
(Ritter et al., 2015). In that study, we found a major impairment in
translation of EGFR transcripts leading to impaired phospho-EGFR
and phospho-ERK1/2 signaling in cumulus cells from low com-
petence oocytes. Importantly, it is known that some aspects ofEGFR functionality can be readily induced in vitro in developing
COCs, such that they become responsive to EGF peptides, including
by exposure to OSFs (Ritter et al., 2015), or by treatment with FSH
(Prochazka et al., 2003).
Mechanistic insights into how the somatic compartment of the
ovarian follicle acquires EGFR signaling capability with progressive
development of the follicle are still emerging. A recent study
demonstrates that FSH is required for expression and activity of
the EGFR in the ovarian follicle, as Fshb-/- mice exhibit impaired
Egfr mRNA expression and defective cumulus cell differentiation
and oocyte maturation, both of which can be restored with exo-
genous FSH administration (El-Hayek et al., 2014). Consistent with
this, pre-treatment of porcine cumulus cells from small antral
follicles with FSH for 3 h, induces EGFR functionality and EGF
responsiveness (Prochazka et al., 2003). In addition, PKA signaling
is required for AREG-induced cumulus cell expansion (Prochazka
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with different letters indicate signiﬁcant difference at Po0.05.
S. Sugimura et al. / Developmental Biology 403 (2015) 139–149146et al., 2012). Together, these studies implicate FSH–cAMP–PKA as a
central pathway; while the present study supports this notion, the
results also suggest this pathway alone is insufﬁcient for estab-
lishment of functional EGFR signaling. We observed major additive
or synergistic beneﬁts from co-treating developing COCs with
cAMP and B15þG9. In less competent COCs, without B15þG9,
cAMP had minimal effects on AREG-mediated oocyte meiotic
maturation, expression of some genes associated with cumulus
expansion, ERK1/2 activation and oocyte developmental compe-
tence. Hence, cooperation between cAMP and OSF signals may be
required for the establishment of EGFR signaling (Fig. 9).
Interestingly, B15þG9 together with cAMP stimulated a blas-
tocyst formation rate which was greater than the rate with
B15þG9 alone or cAMP alone. In C2C12 cells, cAMP–CREB/CRE
signaling enhances Smad-mediated BMP-signaling, following that
transcription of early-response genes to BMPs was increased by
cAMP (Ohta et al., 2008). Hence, as a potential mechanism, cAMP
may enhance B15þG9-induced SMAD signaling, resulting in
increased oocyte competence. In the present study we used
human B15 and human G9 proteins in their full-length pro-mature
forms, which importantly are the forms needed to enhance oocyte
developmental competence, including in AREG-induced IVM
(Hussein et al., 2006; Sudiman et al., 2014b; Sugimura et al., 2014).
By contrast, the truncated mature domains of B15 and G9 do not
enable EGF-stimulated expansion of COCs from small antral folli-
cles (Ritter et al., 2015) and also do not appear to contribute to
oocyte developmental competence (Sudiman et al., 2014a), the
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et al., 2014b). In addition, human B15þG9 can activate not only
SMAD1/5/8 and SMAD2/3, but also non-SMAD signaling pathways
(Reader et al., 2014). It may be necessary to consider the possibility
of cAMP interactions with non-SMAD signaling pathways in the
observed enhanced oocyte competence.
To examine interactions between B15-, G9- and cAMP-promo-
tion of EGF signaling, we examined cumulus expansion and
expression of related genes and activation of ERK1/2, which is
downstream of EGFR. Expression of the matrix-associated genes
HAS2 (Fulop et al., 1997), TNFAIP6 (Fulop et al., 2003) and PTGS2
(Davis et al., 1999), are required for normal cumulus expansion.
These are naturally stimulated by the EGF-like peptides, but
gonadotropins including FSH are highly effective at mimicking
these events, including in COCs from small antral follicles (Ritter
et al., 2015). In porcine COCs, expression of these transcripts is
suppressed by inhibition of EGFR tyrosine kinase and ERK1/2(Gilchrist and Ritter, 2011; Prochazka et al., 2012; Yamashita et al.,
2009), indicating that those cumulus expansion related genes are
strictly regulated by EGFR–ERK1/2 signaling. In the present study,
as can be expected, cAMP, B15þG9 or the combination of cAMP
and B15þG9 did not stimulate morphological cumulus expansion
in their own right, i.e. in the absence of AREG. Notable interactions
were evident between B15þG9 and cAMP on AREG-induced
cumulus expansion and expression of related genes, in particular
of PTGS2. Furthermore, enhancement of ERK1/2 activation by
AREG was observed only when cAMP was combined with
B15þG9. The same combination led to the highest level of oocyte
developmental competence using COCs from small antral follicles,
suggesting that the interactive actions of B15þG9 and cAMP in
terms of promoting AREG-stimulated EGFR–ERK1/2 signaling, is
important in the regulation of oocyte development (Fig. 9).
Collectively the current results add further weight to the notion
that EGFR signaling in developed COCs is central to oocyte
maturation and developmental competence (Chen et al., 2013;
Gilchrist and Richani, 2013; Ritter et al., 2015). To investigate this
further, we examined the effect of inhibiting EGFR signaling on
oocyte competence by using an EGFR tyrosine kinase inhibitor
widely used in the ﬁeld. In the absence of AREG, the inhibitor had
no effect on oocyte meiotic competence and oocyte developmental
competence regardless of B15þG9þcAMP. On the other hand, in
AREG stimulated oocyte maturation, an inhibitory effect was
observed in the presence of cAMPþB15þG9. These results suggest
that the EGFR signaling pathway promoted by oocyte paracrine
factors, such as B15 and G9, together with cAMP, participate in
oocyte meiotic maturation and developmental competence in
small antral follicle-derived COCs. This is consistent with a study of
non-human primate oocytes which indicated that the EGFR sig-
naling pathway is important for not only cumulus expansion and
oocyte meiotic resumption but also for oocyte developmental
competence (Nyholt de Prada et al., 2009).
Cyclic AMP pulsing can induce oocyte maturation via AMP-
activated protein kinase (Chen et al., 2009), and in intact COCs, this
requires both cumulus–oocyte gap junctional communication and
EGFR participation (Downs and Chen, 2008). Together these
results suggest important cross-talk between EGF-peptide/EGFR
and cAMP–PKA signaling pathways, that impact large-scale inter-
cellular communication in the COC, in turn affecting oocyte
developmental competence. In support of this, we previously
showed that the cooperative actions of AREG-stimulated COC
glycolysis and B15-preservation of cumulus–oocyte gap-junctional
communication, facilitates the transfer of metabolites (e.g. NAD(P)
H) from cumulus cells to the oocyte, which is associated with
increased oocyte mitochondrial activity and energy production,
providing a possible mechanism for the improved oocyte devel-
opmental competence (Richani et al., 2014; Sugimura et al., 2014).
EGF-like peptides are the natural mediators of oocyte matura-
tion and ovulation and may also be superior to gonadotropins in
terms of inducing developmental competence of mouse (Richani
et al., 2013), bovine (Sugimura et al., 2014) and porcine (Prochazka
et al., 2011) oocytes from medium and large sized antral follicles.
In less developed COCs from small antral follicles, where EGFR
signaling functions poorly, understandably, AREG does not pro-
mote oocyte or cumulus maturation, or oocyte developmental
competence (current study). However, the results of the present
study demonstrate that cAMP and B15þG9 cooperatively promote
EGFR–ERK1/2 signaling stimulated by AREG in small antral follicle-
derived COCs, resulting in enhanced oocyte developmental com-
petence, to the extent that oocyte competence is higher than that
induced by gonadotropins. Hence, these ﬁndings lead us to
hypothesize (Fig. 9) that endocrine cues, acting via cAMP–PKA,
cooperate with oocyte-secreted paracrine signals, to promote
maturation of the EGFR signaling system in the somatic
Fig. 9. Hypothetical mechanism of cooperation between endocrine cues and oocyte paracrine signals to promote EGFR signaling required for oocyte developmental
competence. The acquisition of EGFR signaling capability by cumulus cells is a developmental hallmark for the COC. Fully grown and meiotically competent COCs in small
antral follicles; have a poor capacity to induce cumulus EGFR functionality, are unresponsive to EGF-peptides (EGF-p), and have low developmental competence (Ritter et al.,
2015). As COCs develop with progressive folliculogenesis, EGFR functionality is induced by the combined actions of gonadotropins/cAMP with the oocyte-secreted factors
(B15 and G9 at least), and is associated with the acquisition by the oocyte for competence to support embryo development. Improved oocyte developmental competence
may be facilitated by EGF-peptide stimulation of cumulus cell glycolysis and provision of metabolites (e.g. NAD(P)H) to the oocyte facilitating oocyte mitochondrial activity
and energy production needed for development.
S. Sugimura et al. / Developmental Biology 403 (2015) 139–149148compartment, and that this directed differentiation of cumulus
cells is a developmental hallmark for the COC required for oocyte
developmental competence.Funding
This study was funded by Grants from the National Health and
Medical Research Council of Australia through Project Grants
(1007551, 1062762), Development Grants (1017484, 1076004) and
Senior Fellowship (1023210), and by research grants from Cook
Medical and from a Japanese Society for the Promotion of Science
Postdoctoral Fellowship for Research Abroad awarded to S.S.Acknowledgments
The authors wish to thank the members of the Oocyte Biology
and Early Developmental Groups at the University of Adelaide and
Ben Allford for ovary collections and Big River Pork Abattoir.References
Albuz, F.K., Sasseville, M., Lane, M., Armstrong, D.T., Thompson, J.G., Gilchrist, R.B.,
2010. Simulated physiological oocyte maturation (SPOM): a novel in vitro
maturation system that substantially improves embryo yield and pregnancy
outcomes. Hum. Reprod. 25, 2999–3011.
Bagg, M.A., Nottle, M.B., Armstrong, D.T., Grupen, C.G., 2007. Relationship between
follicle size and oocyte developmental competence in prepubertal and adult
pigs. Reprod. Fertil. Dev. 19, 797–803.
Buccione, R., Vanderhyden, B.C., Caron, P.J., Eppig, J.J., 1990. FSH-induced expansion
of the mouse cumulus oophorus in vitro is dependent upon a speciﬁc factor
(s) secreted by the oocyte. Dev. Biol. 138, 16–25.
Caixeta, E.S., Ripamonte, P., Franco, M.M., Junior, J.B., Dode, M.A., 2009. Effect of
follicle size on mRNA expression in cumulus cells and oocytes of Bos indicus: an
approach to identify marker genes for developmental competence. Reprod.
Fertil. Dev. 21, 655–664.
Chen, J., Chi, M.M., Moley, K.H., Downs, S.M., 2009. cAMP pulsing of denuded mouse
oocytes increases meiotic resumption via activation of AMP-activated protein
kinase. Reproduction 138, 759–770.
Chen, J., Torcia, S., Xie, F., Lin, C.J., Cakmak, H., Franciosi, F., Horner, K., Onodera, C.,
Song, J.S., Cedars, M.I., Ramalho-Santos, M., Conti, M., 2013. Somatic cells reg-
ulate maternal mRNA translation and developmental competence of mouse
oocytes. Nat. Cell Biol. 15, 1415–1423.
Conti, M., Hsieh, M., Park, J.Y., Su, Y.Q., 2006. Role of the epidermal growth factor
network in ovarian follicles. Mol. Endocrinol. 20, 715–723.Conti, M., Hsieh, M., Zamah, A.M., Oh, J.S., 2012. Novel signaling mechanisms in the
ovary during oocyte maturation and ovulation. Mol. Cell Endocrinol. 356,
65–73.
Davis, B.J., Lennard, D.E., Lee, C.A., Tiano, H.F., Morham, S.G., Wetsel, W.C., Lan-
genbach, R., 1999. Anovulation in cyclooxygenase-2-deﬁcient mice is restored
by prostaglandin E2 and interleukin-1beta. Endocrinology 140, 2685–2695.
Diaz, F.J., Wigglesworth, K., Eppig, J.J., 2007. Oocytes are required for the preantral
granulosa cell to cumulus cell transition in mice. Dev. Biol. 305, 300–311.
Dong, J., Albertini, D.F., Nishimori, K., Kumar, T.R., Lu, N., Matzuk, M.M., 1996.
Growth differentiation factor-9 is required during early ovarian folliculogenesis.
Nature 383, 531–535.
Downs, S.M., Chen, J., 2008. EGF-like peptides mediate FSH-induced maturation of
cumulus cell-enclosed mouse oocytes. Mol. Reprod. Dev. 75, 105–114.
El-Hayek, S., Demeestere, I., Clarke, H.J., 2014. Follicle-stimulating hormone reg-
ulates expression and activity of epidermal growth factor receptor in the
murine ovarian follicle. Proc. Natl. Acad. Sci. USA 111, 16778–16783.
Eppig, J.J., 2001. Oocyte control of ovarian follicular development and function in
mammals. Reproduction 122, 829–838.
Eppig, J.J., Schroeder, A.C., O'Brien, M.J., 1992. Developmental capacity of mouse
oocytes matured in vitro: effects of gonadotrophic stimulation, follicular origin
and oocyte size. J. Reprod. Fertil. 95, 119–127.
Eppig, J.J., Schultz, R.M., O'Brien, M., Chesnel, F., 1994. Relationship between the
developmental programs controlling nuclear and cytoplasmic maturation of
mouse oocytes. Dev. Biol. 164, 1–9.
Eppig, J.J., Wigglesworth, K., Pendola, F., Hirao, Y., 1997. Murine oocytes suppress
expression of luteinizing hormone receptor messenger ribonucleic acid by
granulosa cells. Biol. Reprod. 56, 976–984.
Erickson, G.F., Wang, C., Hsueh, A.J., 1979. FSH induction of functional LH receptors
in granulosa cells cultured in a chemically deﬁned medium. Nature 279,
336–338.
Fagbohun, C.F., Downs, S.M., 1990. Maturation of the mouse oocyte–cumulus cell
complex: stimulation by lectins. Biol. Reprod. 42, 413–423.
Fulop, C., Salustri, A., Hascall, V.C., 1997. Coding sequence of a hyaluronan synthase
homologue expressed during expansion of the mouse cumulus–oocyte com-
plex. Arch. Biochem. Biophys. 337, 261–266.
Fulop, C., Szanto, S., Mukhopadhyay, D., Bardos, T., Kamath, R.V., Rugg, M.S., Day, A.
J., Salustri, A., Hascall, V.C., Glant, T.T., Mikecz, K., 2003. Impaired cumulus
muciﬁcation and female sterility in tumor necrosis factor-induced protein-6
deﬁcient mice. Development 130, 2253–2261.
Funahashi, H., Cantley, T.C., Day, B.N., 1997. Synchronization of meiosis in porcine
oocytes by exposure to dibutyryl cyclic adenosine monophosphate improves
developmental competence following in vitro fertilization. Biol. Reprod. 57,
49–53.
Gilchrist, R.B., Richani, D., 2013. Somatic guidance for the oocyte. Dev. Cell 27,
603–605.
Gilchrist, R.B., Ritter, L.J., 2011. Differences in the participation of TGFB superfamily
signalling pathways mediating porcine and murine cumulus cell expansion.
Reproduction 142, 647–657.
Gilchrist, R.B., Ritter, L.J., Myllymaa, S., Kaivo-Oja, N., Dragovic, R.A., Hickey, T.E.,
Ritvos, O., Mottershead, D.G., 2006. Molecular basis of oocyte-paracrine sig-
nalling that promotes granulosa cell proliferation. J. Cell Sci. 119, 3811–3821.
Gilchrist, R.B., Thompson, J.G., 2007. Oocyte maturation: emerging concepts and
technologies to improve developmental potential in vitro. Theriogenology 67,
6–15.
S. Sugimura et al. / Developmental Biology 403 (2015) 139–149 149Gonzalez-Robayna, I.J., Falender, A.E., Ochsner, S., Firestone, G.L., Richards, J.S.,
2000. Follicle-Stimulating hormone (FSH) stimulates phosphorylation and
activation of protein kinase B (PKB/Akt) and serum and glucocorticoid-lnduced
kinase (Sgk): evidence for A kinase-independent signaling by FSH in granulosa
cells. Mol. Endocrinol. 14, 1283–1300.
Hsieh, M., Lee, D., Panigone, S., Horner, K., Chen, R., Theologis, A., Lee, D.C.,
Threadgill, D.W., Conti, M., 2007. Luteinizing hormone-dependent activation of
the epidermal growth factor network is essential for ovulation. Mol. Cell Biol.
27, 1914–1924.
Hussein, T.S., Froiland, D.A., Amato, F., Thompson, J.G., Gilchrist, R.B., 2005. Oocytes
prevent cumulus cell apoptosis by maintaining a morphogenic paracrine gra-
dient of bone morphogenetic proteins. J. Cell Sci. 118, 5257–5268.
Hussein, T.S., Thompson, J.G., Gilchrist, R.B., 2006. Oocyte-secreted factors enhance
oocyte developmental competence. Dev. Biol. 296, 514–521.
Laitinen, M., Vuojolainen, K., Jaatinen, R., Ketola, I., Aaltonen, J., Lehtonen, E., Hei-
kinheimo, M., Ritvos, O., 1998. A novel growth differentiation factor-9 (GDF-9)
related factor is co-expressed with GDF-9 in mouse oocytes during folliculo-
genesis. Mech. Dev. 78, 135–140.
Li, J.J., Sugimura, S., Mueller, T.D., White, M.A., Martin, G.A., Ritter, L.J., Liang, X.Y.,
Gilchrist, R.B., Mottershead, D.G., 2015. Modiﬁcations of human growth differ-
entiation factor 9 to improve the generation of embryos from low competence
oocytes. Mol. Endocrinol. 29, 40–52.
Li, R., Norman, R.J., Armstrong, D.T., Gilchrist, R.B., 2000. Oocyte-secreted factor
(s) determine functional differences between bovine mural granulosa cells and
cumulus cells. Biol. Reprod. 63, 839–845.
Lonergan, P., Monaghan, P., Rizos, D., Boland, M.P., Gordon, I., 1994. Effect of follicle
size on bovine oocyte quality and developmental competence following
maturation, fertilization, and culture in vitro. Mol. Reprod. Dev. 37, 48–53.
Luciano, A.M., Pocar, P., Milanesi, E., Modina, S., Rieger, D., Lauria, A., Gandolﬁ, F.,
1999. Effect of different levels of intracellular cAMP on the in vitro maturation
of cattle oocytes and their subsequent development following in vitro fertili-
zation. Mol. Reprod. Dev. 54, 86–91.
Marchal, R., Vigneron, C., Perreau, C., Bali-Papp, A., Mermillod, P., 2002. Effect of
follicular size on meiotic and developmental competence of porcine oocytes.
Theriogenology 57, 1523–1532.
Miyoshi, K., Umezu, M., Sato, E., 1999. Effect of hyaluronic acid on the development
of porcine 1-cell embryos produced by a conventional or new in vitro
maturation/fertilization system. Theriogenology 51, 777–784.
Mtango, N.R., Potireddy, S., Latham, K.E., 2008. Oocyte quality and maternal control
of development. Int. Rev. Cell Mol. Biol. 268, 223–290.
Norris, R.P., Freudzon, M., Nikolaev, V.O., Jaffe, L.A., 2010. Epidermal growth factor
receptor kinase activity is required for gap junction closure and for part of the
decrease in ovarian follicle cGMP in response to LH. Reproduction 140,
655–662.
Nyholt de Prada, J.K., Lee, Y.S., Latham, K.E., Chafﬁn, C.L., VandeVoort, C.A., 2009.
Role for cumulus cell-produced EGF-like ligands during primate oocyte
maturation in vitro. American journal of physiology. Endocrinol. Metab. 296,
E1049–E1058.
Ohta, Y., Nakagawa, K., Imai, Y., Katagiri, T., Koike, T., Takaoka, K., 2008. Cyclic AMP
enhances Smad-mediated BMP signaling through PKA–CREB pathway. J. Bone
Min. Metab. 26, 478–484.
Paradis, F., Moore, H.S., Pasternak, J.A., Novak, S., Dyck, M.K., Dixon, W.T., Foxcroft, G.
R., 2010. Pig preovulatory oocytes modulate cumulus cell protein and gene
expression in vitro. Mol. Cell. Endocrinol. 320, 87–96.
Park, J.Y., Su, Y.Q., Ariga, M., Law, E., Jin, S.L., Conti, M., 2004. EGF-like growth factors
as mediators of LH action in the ovulatory follicle. Science 303, 682–684.
Prochazka, R., Blaha, M., Nemcova, L., 2012. Signaling pathways regulating FSH- and
amphiregulin-induced meiotic resumption and cumulus cell expansion in the
pig. Reproduction 144, 535–546.
Prochazka, R., Kalab, P., Nagyova, E., 2003. Epidermal growth factor-receptor tyr-
osine kinase activity regulates expansion of porcine oocyte–cumulus cell
complexes in vitro. Biol. Reprod. 68, 797–803.
Prochazka, R., Petlach, M., Nagyova, E., Nemcova, L., 2011. Effect of epidermal
growth factor-like peptides on pig cumulus cell expansion, oocyte maturation,
and acquisition of developmental competence in vitro: comparison with
gonadotropins. Reproduction 141, 425–435.
Prochazka, R., Srsen, V., Nagyova, E., Miyano, T., Flechon, J.E., 2000. Developmental
regulation of effect of epidermal growth factor on porcine oocyte-cumulus cell
complexes: nuclear maturation, expansion, and F-actin remodeling. Mol.
Reprod. Dev. 56, 63–73.
Pulkki, M.M., Mottershead, D.G., Pasternack, A.H., Muggalla, P., Ludlow, H., van
Dinther, M., Myllymaa, S., Koli, K., ten Dijke, P., Laitinen, M., Ritvos, O., 2012. Acovalently dimerized recombinant human bone morphogenetic protein-15
variant identiﬁes bone morphogenetic protein receptor type 1B as a key cell
surface receptor on ovarian granulosa cells. Endocrinology 153, 1509–1518.
Pulkki, M.M., Myllymaa, S., Pasternack, A., Lun, S., Ludlow, H., Al-Qahtani, A.,
Korchynskyi, O., Groome, N., Juengel, J.L., Kalkkinen, N., Laitinen, M., Ritvos, O.,
Mottershead, D.G., 2011. The bioactivity of human bone morphogenetic pro-
tein-15 is sensitive to C-terminal modiﬁcation: characterization of the puriﬁed
untagged processed mature region. Mol. Cell. Endocrinol. 332, 106–115.
Quinn, P., Barros, C., Whittingham, D.G., 1982. Preservation of hamster oocytes to
assay the fertilizing capacity of human spermatozoa. J. Reprod. Fertil. 66,
161–168.
Reader, K.L., Mottershead, D.G., Martin, G.A., Gilchrist, R.B., Heath, D.A., McNatty, K.
P., Juengel, J.L., 2014. Signalling pathways involved in the synergistic effects of
human growth differentiation factor 9 and bone morphogenetic protein 15.
Reprod. Fertil. Dev., Epub 26/8/2014
Regassa, A., Rings, F., Hoelker, M., Cinar, U., Tholen, E., Looft, C., Schellander, K.,
Tesfaye, D., 2011. Transcriptome dynamics and molecular cross-talk between
bovine oocyte and its companion cumulus cells. BMC Genomics 12, 57.
Richani, D., Ritter, L.J., Thompson, J.G., Gilchrist, R.B., 2013. Mode of oocyte
maturation affects EGF-like peptide function and oocyte competence. Mol.
Hum. Reprod. 18, 500–509.
Richani, D., Sutton-McDowall, M.L., Frank, L.A., Gilchrist, R.B., Thompson, J.G., 2014.
Effect of epidermal growth factor-like peptides on the metabolism of in vitro-
matured mouse oocytes and cumulus cells. Biol. Reprod. 90, 49.
Ritter, L.J., Sugimura, S., Gilchrist, R.B., 2015. Oocyte induction of EGF responsive-
ness in somatic cells is associated with the acquisition of porcine oocyte
developmental competence. Endocrinology 156, 2299–2312.
Sasseville, M., Ritter, L.J., Nguyen, T.M., Liu, F., Mottershead, D.G., Russell, D.L.,
Gilchrist, R.B., 2010. Growth differentiation factor 9 signaling requires ERK1/2
activity in mouse granulosa and cumulus cells. J. Cell Sci. 123, 3166–3176.
Shimada, M., Hernandez-Gonzalez, I., Gonzalez-Robayna, I., Richards, J.S., 2006.
Paracrine and autocrine regulation of epidermal growth factor-like factors in
cumulus oocyte complexes and granulosa cells: key roles for prostaglandin
synthase 2 and progesterone receptor. Mol. Endocrinol. 20, 1352–1365.
Su, Y.Q., Sugiura, K., Li, Q., Wigglesworth, K., Matzuk, M.M., Eppig, J.J., 2010. Mouse
oocytes enable LH-induced maturation of the cumulus–oocyte complex via
promoting EGF receptor-dependent signaling. Mol. Endocrinol. 24, 1230–1239.
Sudiman, J., Ritter, L.J., Feil, D.K., Wang, X., Chan, K., Mottershead, D.G., Robertson, D.
M., Thompson, J.G., Gilchrist, R.B., 2014. Effects of differing oocyte-secreted
factors during mouse in vitro maturation on subsequent embryo and fetal
development. J. Assist. Reprod. Genet. 31, 295–306.
Sudiman, J., Sutton-McDowall, M.L., Ritter, L.J., White, M.A., Mottershead, D.G.,
Thompson, J.G., Gilchrist, R.B., 2014b. Bone morphogenetic protein 15 in the
pro-mature complex form enhances bovine oocyte developmental competence.
PLoS One 9 (7), e103563.
Sugimura, S., Ritter, L.J., Sutton-McDowall, M.L., Mottershead, D.G., Thompson, J.G.,
Gilchrist, R.B., 2014. Amphiregulin co-operates with bone morphogenetic pro-
tein 15 to increase bovine oocyte developmental competence: effects on gap
junction-mediated metabolite supply. Mol. Hum. Reprod. 20, 499–513.
Sugiura, K., Su, Y.Q., Diaz, F.J., Pangas, S.A., Sharma, S., Wigglesworth, K., O'Brien, M.
J., Matzuk, M.M., Shimasaki, S., Eppig, J.J., 2007. Oocyte-derived BMP15 and
FGFs cooperate to promote glycolysis in cumulus cells. Development 134,
2593–2603.
Suzuki, C., Iwamura, S., Yoshioka, K., 2004. Birth of piglets through the non-surgical
transfer of blastocysts produced in vitro. J. Reprod. Dev. 50, 487–491.
Vanderhyden, B.C., Caron, P.J., Buccione, R., Eppig, J.J., 1990. Developmental pattern
of the secretion of cumulus expansion-enabling factor by mouse oocytes and
the role of oocytes in promoting granulosa cell differentiation. Dev. Biol. 140,
307–317.
Yamashita, Y., Hishinuma, M., Shimada, M., 2009. Activation of PKA, p38 MAPK and
ERK1/2 by gonadotropins in cumulus cells is critical for induction of EGF-like
factor and TACE/ADAM17 gene expression during in vitro maturation of porcine
COCs. J. Ovarian Res. 2, 20.
Yamashita, Y., Kawashima, I., Yanai, Y., Nishibori, M., Richards, J.S., Shimada, M.,
2007. Hormone-induced expression of tumor necrosis factor alpha-converting
enzyme/A disintegrin and metalloprotease-17 impacts porcine cumulus cell
oocyte complex expansion and meiotic maturation via ligand activation of the
epidermal growth factor receptor. Endocrinology 148, 6164–6175.
Yoshioka, K., Suzuki, C., Onishi, A., 2008. Deﬁned system for in vitro production of
porcine embryos using a single basic medium. J. Reprod. Dev. 54, 208–213.
